Australia markets close in 4 hours 55 minutes

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
262.88-5.94 (-2.21%)
At close: 04:00PM EST
263.00 +0.12 (+0.05%)
After hours: 06:58PM EST
Full screen
Trade prices are not sourced from all markets
Previous close268.82
Bid250.00 x 1100
Ask301.00 x 1100
Day's range251.84 - 271.51
52-week range162.29 - 327.32
Avg. volume416,636
Market cap14.534B
Beta (5Y monthly)0.81
PE ratio (TTM)125.12
EPS (TTM)2.10
Earnings date22 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est318.11
  • GlobeNewswire

    Repligen Corporation to Present at Upcoming Investor Conferences

    WALTHAM, Mass., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at two upcoming investor conferences. Stifel’s 2021 Virtual Healthcare Conference being held November 15-17. Tony J. Hunt, President and Chief Executive Officer, will participate in a fireside chat on Wednesday, November 17, at 8:00 a.m. EST.Stephens Annual Investment Conference being held December 1-3.

  • GlobeNewswire

    Repligen Releases Inaugural Sustainability Report

    Sets Baseline and Provides SASB, GRI Core and SDG DisclosuresWALTHAM, Mass., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today released its inaugural sustainability report, available on the Company’s website. Repligen’s 2020 Sustainability Report provides an overview of the Company’s environmental, social and governance (ESG) performance in 2020 and into 2021, and provides disclosures aligned to three key reporting frameworks; the Value Reporting Foundation’s SASB Medic

  • Zacks

    Repligen (RGEN) Q3 Earnings and Sales Beat, 2021 View Up

    Repligen's (RGEN) third-quarter earnings and revenues beat estimates. The company raises its guidance for 2021. Resultantly, the stock rises.